Matthew Wolfson Electromedical Technologies, Inc (EMED) insider trading activity
Matthew Wolfson is CEO, CFO of Electromedical Technologies, Inc. Currently has a direct ownership of 15.3 Million shares of EMED, which is worth approximately $0. The most recent transaction as insider was on Feb 17, 2021, when has been sold 1,100,000 shares (Common) at a price of $0.54 per share, resulting in proceeds of $594,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
15.3M
0%
3M change
0%
12M change
Total Value Held
$0
MW
Matthew Wolfson
CEO, CFO
Scottsdale, AZ